PCSK9 and cardiovascular disorder: The proprotein convertase subtilisin/kexin type 9 (PCSK9) gene can bind to the low-density lipoproteins receptor (LDLR) domain, resulting in an increase in the level of circulating LDL-C and a higher level of LDL-C, allowing for an increased incidence of cardiovascular disease [170].